It is simple. This is yet another biotech that listed too early, talks big then but fails to execute and misses milestones..
The IPO presentation said they would "partner their lead candidate in CY2018."
https://www.asx.com.au/asxpdf/20160822/pdf/439hc66h4bflyk.pdf
Ann: Major shareholder fund expiry extended, page-6
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $13.33M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $5.018K | 238.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1176841 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 234999 | 1 |
View Market Depth
| Last trade - 10.00am 09/09/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |